如何应对间歇性囊炎/膀疼痛综合征
Susanna Sutherland1, A Grace Kelly2,3, Lindsey C McKernan1,3,4,5
1Osher Center for Integrative Health, Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Neurourology and urodynamics
|September 16, 2024
概括
患有间歇性囊炎/膀疼痛综合征 (IC/BPS) 的女性使用脱节应对策略,会经历更多的心理痛苦. 了解应对机制是开发有效IC/BPS干预措施的关键.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 心理学 心理学 心理学
- 疼痛管理 疼痛管理
背景情况:
- 补偿性应对行为越来越多地在膀疾病中得到认可,例如间歇性囊炎/膀疼痛综合征 (IC/BPS).
- 以前的研究已经将应对行为与心理痛苦联系起来,但没有区分应对策略或其适应潜力.
- 应对机制的异质性及其对IC/BPS中痛苦的不同影响需要进一步调查.
研究的目的:
- 为了检查初级控制应对和脱离应对行为和IC/BPS妇女的痛苦之间的关系.
- 探索疼痛表型在调解应对行为和心理痛苦之间的关联中的作用.
- 确定特定的应对策略,可以预测困境,并为IC/BPS提供干预开发信息.
主要方法:
- 对一个大型社区数据集的二次数据分析,包括677名被诊断为IC/BPS的妇女.
- 描述性和推断性统计方法被用来分析应对模式和痛苦的预测因素.
- 采用多重回归模型来评估应对行为,疼痛表型和心理痛苦之间的关联,控制临床变量.
主要成果:
- 几乎所有参与者都报告说,他们至少有一种补偿性应对行为.
- 主要控制和脱节的应对行为都与心理症状相关.
- 脱离应对行为与心理困扰有显著的关联,即使在控制年龄和尿道症状严重程度之后.
- 将疼痛表型纳入回归模型,改善了与应对行为相关的抑郁症预测.
结论:
- 脱离应对是IC/BPS妇女心理痛苦的重要预测因素.
- 了解应对策略的细微差别,包括疼痛表型,对于开发有针对性的干预措施至关重要.
- 对应对机制的进一步研究可以提高我们对风险因素的理解,并为IC/BPS患者提供更有效的治疗方法.
相关概念视频
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
180
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
180
01:21Drugs for Treatment of Constipation-Predominant IBS
145
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
145
01:17Drugs for Treatment of Diarrhea-Predominant IBS
153
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
153
01:20Disorders of the Urinary System
264
The urinary system is responsible for eliminating waste and excess fluids from the body. However, disorders of the urinary system can arise due to various reasons like infections, stress, age, congenital abnormalities, and lifestyle.
Urinary tract infections (UTIs) are one of the most common urinary system disorders. They are caused by bacteria that enter the urethra and can spread to the bladder resulting in cystitis. Pyelonephritis is the result of a UTI that has ascended to the level of the...
Urinary tract infections (UTIs) are one of the most common urinary system disorders. They are caused by bacteria that enter the urethra and can spread to the bladder resulting in cystitis. Pyelonephritis is the result of a UTI that has ascended to the level of the...
264
01:17Irritable Bowel Syndrome I: Introduction
257
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
257
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
147
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
147